Anti-15-LOX-2 antibody,Abcam,AB23691

Host

Rabbit

Reactivity

Human, Pig

Application

WB

Platform ID

BAB266239024

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-15-LOX-2 antibody
Cat. No.AB23691
HostRabbit
IsotypeIgG
ReactivityHuman, Pig
ApplicationWB
ClonalityPolyclonal
Concentration0.8 mg/mL Batch dependent concentration
ImmunogenSynthetic Peptide within Human ALOX15B aa 150-200. The exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Immunogen
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Preservative: 0.02% Sodium azide Constituents: Tris buffered saline, 50% Glycerol (glycerin, glycerine), 0.1% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Isoform A. Non-heme iron-containing dioxygenase that catalyzes the stereo-specific peroxidation of free and esterified polyunsaturated fatty acids (PUFAs) generating a spectrum of bioactive lipid mediators (Probable) (PubMed : 10542053, PubMed : 10625675, PubMed : 12704195, PubMed : 17493578, PubMed : 18311922, PubMed : 24282679, PubMed : 24497644, PubMed : 32404334, PubMed : 9177185). It inserts peroxyl groups at C15 of arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate) producing (15S)-hydroperoxyeicosatetraenoate/(15S)-HPETE (Probable) (PubMed : 10625675, PubMed : 11956198, PubMed : 12704195, PubMed : 17493578, PubMed : 24282679, PubMed : 24497644, PubMed : 9177185). Also peroxidizes linoleate ((9Z,12Z)-octadecadienoate) to 13-hydroperoxyoctadecadienoate/13-HPODE (Probable) (PubMed : 10542053, PubMed : 27435673). Oxygenates arachidonyl derivatives such as 2-arachidonoylglycerol (2-AG) leading to the production and extracellular release of 15-hydroxyeicosatetraenoyl glycerol (15-HETE-G) that acts as a peroxisome proliferator-activated receptor alpha agonist (PubMed : 11956198, PubMed : 17493578, PubMed : 18311922). Has the ability to efficiently class-switch ALOX5 pro-inflammatory mediators into anti-inflammatory intermediates (PubMed : 27145229). Participates in the sequential oxidations of DHA ((4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate) to generate specialized pro-resolving mediators (SPMs) resolvin D5 ((7S,17S)-diHPDHA), which can actively down-regulate the immune response and have anti-aggregation properties with platelets (PubMed : 32404334). In addition to free PUFAs hydrolyzed from phospholipids, it directly oxidizes PUFAs esterified to membrane-bound phospholipids (PubMed : 27435673). Has no detectable 8S-lipoxygenase activity on arachidonate but reacts with (8S)-HPETE to produce (8S,15S)-diHPETE (Probable). May regulate progression through the cell cycle and cell proliferation (PubMed : 11839751, PubMed : 12704195). May also regulate cytokine secretion by macrophages and therefore play a role in the immune response (PubMed : 18067895). May also regulate macrophage differentiation into proatherogenic foam cells (PubMed : 22912809).. Isoform B. Does not convert arachidonic acid to 15S-hydroperoxyeicosatetraenoic acid/(15S)-HPETE. See full target information ALOX15B

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.